Bright auroras on Jupiter are captured by Webb Space Telescope
WASHINGTON (AP) — Jupiter's dazzling auroras are hundreds of times brighter than those seen on Earth, new images from the James Webb Space Telescope reveal.
The solar system's largest planet displays striking dancing lights when high-energy particles from space collide with atoms of gas in the atmosphere near its magnetic poles, similar to how the northern lights are triggered on Earth.
But Jupiter's version has much greater intensity, according to an international team of scientists who analyzed the photos from Webb taken on Christmas in 2023.
Webb previously captured Neptune's glowing auroras in the best detail yet, many decades after they were first faintly detected during a flyby of the Voyager 2 spacecraft.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Fapon Biopharma to Showcase Differentiated Pipeline, Including Phase 1 Immunocytokine FP008, and Innovative Technology Platforms at BIO 2025
BOSTON, June 12, 2025 /PRNewswire/ -- Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased to announce its participation in the BIO International Convention 2025 (BIO 2025), taking place June 16-19 in Boston Convention & Exhibition Center. The company will exhibit at Booth #1851, presenting its differentiated pipeline, including the flagship Phase 1 immunocytokine FP008, a portfolio of promising early-stage candidates for oncology and autoimmune diseases, and its suite of proprietary technology platforms, while actively seeking global partnerships. FP008, Fapon Biopharma's lead asset, is a first-in-class immunocytokine currently in Phase 1 clinical trials, designed to address significant unmet needs in solid tumor patient refractory to anti-PD-1 therapy. The company will also feature promising preclinical candidates targeting oncology (FP010, FP011, FPE021) and autoimmune diseases (FPE022, FPE024), highlighting its expanding research capabilities. Fapon Biopharma will feature its proprietary and innovative technology platforms, engineered to overcome complex drug development challenges: Bi/Tri-TCE Platform: Human-monkey cross-reactive TCR/CD3 nanobody, enabling the design of potent multi-specific antibodies for targeted cancer immunotherapy. FILTEN™ (IL-10M Fusion Protein Platform): Overcoming IL-10 limitations for broad applications in cancer and autoimmune diseases PROTiNb™ (Proteolysis Targeting Intra-Nanobody): A pioneering platform targeting previously "undruggable" intracellular targets, demonstrating a strong competitive edge. FIND™ Mammalian Cell Display Platform: Accelerating antibody discovery by combining mammalian cell expression with high-throughput screening. "We are excited to connect with the global biopharma community at BIO 2025," said Vincent Huo, President of Fapon Biopharma. "We look forward to demonstrating the exciting progress of our internal pipeline and how our technology platforms can empower external partners to bring transformative therapy to patients faster." Engagement Opportunities:Exhibition Booth: #1851Company Presentation: Time: 11:30 a.m., Tuesday, June 17, 2025Location: Room 153A, Boston Convention & Exhibition Center To schedule a meeting in advance or during the conference, please contact our BD representatives, Max Wang ( and Liyan Gao ( or visit us at Booth #1851. Meetings can also be requested via the BIO partnering system. About Fapon Biopharma ( Fapon Biopharma specializes in discovering and developing biologics for treating cancers, autoimmune diseases and other diseases where there are unmet medical needs. Leveraging cutting-edge technologies, we have built advanced drug discovery platforms, including an antibody discovery platform based on the globally leading mammalian cell display technology, a platform for generating IL-10M fusion proteins, and a platform for developing multispecific antibodies using Fibody and nanobodies. With a differentiated pipeline of leading drug candidates, we have established capabilities that cover the entire drug development process from drug discovery, preclinical research, Chemistry, Manufacturing and Controls (CMC) to early clinical development. Committed to innovation, we strive to deliver safer, more efficacious, affordable, and accessible biologics for everyone. View original content to download multimedia: SOURCE Fapon Biopharma Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Medscape
an hour ago
- Medscape
Cannabis Use Common in Teens With Chronic Pain, Study Finds
Roughly one quarter of teens presenting at a pain clinic reported using cannabis, with the majority saying they used the drug to cope with symptoms related to chronic pain, according to new findings published in JAMA Network Open . These teens used the drug to alleviate their physical symptoms, as well as anxiety, poor sleep, or nausea. Researchers said teenagers who use marijuana increase their risk of developing adverse effects associated with the drug, such as worsening anxiety and depression. 'What concerns me most is the heightened risk of developing cannabis use disorder,' said Joe Kossowsky, PhD, MMSc, an assistant professor of anesthesia at Harvard Medical School in Boston, the lead author of the study. The rising potency of tetrahydrocannabinol, the main psychoactive substance in cannabis, may compound the risks for adverse effects among youth who use the drug, he said. Kossowsky said he conducted the research to find out the extent to which teens with chronic pain used marijuana. Between 2021 and 2024, he and his colleagues recruited teens aged 14-19 years with diagnosed chronic pain conditions from a Boston pediatric pain clinic. Of 245 teens, 14 said they had used cannabis for recreational purposes and 48 said they had used the drug to manage their chronic pain. The participants in the study completed surveys detailing the characteristics of their pain, frequency and reason for cannabis use, adverse effects, and beliefs around cannabis. They also filled out surveys detailing the extent to which pain interfered with daily activities such as running or standing, called pain interference. The age of first cannabis use ranged from age 7-19 years (mean age, 15.3 years). Overall, teens reported having used cannabis over the previous year on a median of six to nine occasions. Most teens used edibles (51.6%), vapes (45.2%), and joints (43.5%) to consume marijuana. The group younger than 18 years who said they had used cannabis for any reason reported slightly higher scores of pain interference than the group that had not used the drug. Their depressive symptoms scores were also higher than those who had not used. Youth using marijuana to manage symptoms were a year younger on average than those who said they used it recreationally (mean difference, −0.7 years; 95% CI, −1.3 to −0.1 years; P = .04) and also reported greater functional disability (mean difference, 8.4; 95% CI, 2.1-12.6; P = .01). Kossowsky told Medscape Medical News that he also found that those using marijuana to manage symptoms consumed it more frequently and had started at a younger age than those who used it recreationally; findings that were not included in the current research but that he said he plans on publishing in another study. Initially, cannabis affects the endocannabinoid system, decreasing pain at the level of peripheral nerves, the spinal cord, and the brain. 'It does initially provide the relief that they're looking for,' Kossowsky said. But the nerve receptors in these areas become less responsive over time, necessitating heavier use of the drug to achieve the same level of relief. This cycle can increase the risk that a teen develops cannabis use disorder, Kossowsky said. The long-term consequences of cannabis use are amplified during the developmental window of adolescence, said Sharon Levy, MD, chief of the Division of Addiction Medicine at Boston Children's Hospital, Boston. The part of the brain that pursues pleasure is developing rapidly, and dopamine receptors that signal pleasure are at their lifetime densest. 'There's a drive to do things that are going to cause a lot of dopamine firing,' which can include using cannabis, Levey said. Meanwhile, the prefrontal cortex, the seat of executive functions that supports sound decision-making, is still immature and cannot be counted on for reliable input, Levy said. This developmental imbalance is the reason that substance use is particularly common among adolescents, Levy said. Cannabis use during adolescence is associated with worse functional outcomes, such as diminished verbal memory and attention, poorer educational achievements, mental health disorders like anxiety, depression, psychosis, and addiction. Kossowsky said he hopes his study will alert clinicians to the challenges faced by adolescents with chronic pain. 'I'm hoping there will definitely be more screening done and interventional work,' he said. Participants in the study who used cannabis to manage chronic pain tended to think that the drug was safe because it was natural, the study showed. By contrast, their peers who did not consume cannabis were more aware of the risks of such usage, including worsening their medical problems and developing addiction to the substance. Clinicians should also treat the pain, anxiety, and disrupted sleep that prompts patients to use cannabis. 'You can't take that away from them without providing them with something else that helps,' Kossowsky said. The first-line treatment is an integrative approach combining cognitive behavior therapy with physiotherapy. Medications can be added as needed, such as selective serotonin reuptake inhibitors to alleviate anxiety. Kossowsky said he is currently tracking the same cohort of teens with chronic pain over 5 years. 'This study is a first effort to shed light on a complex issue,' Kossowsky said. 'But now what we're seeing has definitely warranted going a step further.' This study was funded by the National Institute on Drug Abuse. The researchers reported no relevant financial conflicts of interest.
Forbes
an hour ago
- Forbes
CETI Looks Into The Complexities Of Whale Sounds With AI
What can we learn from the whales? It's something that researchers at the CETI project (not to be confused with the SETI Institute) are working on in order to help drive awareness around language models that exist right here in our own world. In a recent TED talk, CETI's Pratyusha Sharma talks about the communication of sperm whales, and how humans can use that to learn more about other species and ourselves. Sharma is a graduate student at CSAIL and works with advisors like our own Daniela Rus to advance this kind of discovery. As a starter, she gave the example of aliens speaking to humans verbally, or through a script – and again, distinguish CETI from what they're doing in space research! 'Communication is a key characteristic of intelligence,' Sharma explained. 'Being able to create an infinite set of messages by sequencing together finite sets of sounds is what has distinguished human beings from other species.' However, she said, CETI research indicates that we may not be alone on the earth in developing these kinds of systems. In figuring this out, she suggested, we can get insights on other species, and understand our own language better as well. Millions of life forms on earth, she said, share some form of language. 'They have their own physical and mental constraints, and are involved in their own unique ecosystems and societies,' she said. 'However, we know very little about – their communications.' So how do you decipher them? In further explaining what goes on at CETI, she listed different stakeholders with credentials in areas like linguistics, biology, cryptography and AI. (Here's some more background on the project). Most of the research, she said, is taking place in the Dominican Republic, or in the Caribbean. Explaining how the large brains of sperm whales have evolved over 16 million years, she described activity that shows advanced thinking: 'The members of the family coordinate their dives, engage in extended periods of socialization, and even take turns babysitting each other's young ones,' she said. 'While coordinating in complete darkness, they exchange long sequences of sounds with one another.' The question, she noted, is this: what are they saying? Researchers at CETI have identified 21 types of 'codas' or call systems with a certain complexity. 'One of the key differentiators between human language and all animal communications is that beautiful property called duality of patterning,' Sharma said. 'It's how a base set of individually meaningless elements sequence together to give rise to words, that in turn are sequenced together to give rise to an infinite space with complex meaning.' She outlined some of the principles through which CETI is building this species knowledge. 'Getting to the point of understanding the communications of sperm whales will require us to understand what features of their (vocalizations) they control,' she said. Presenting a set of 'coda visualizations,' Sharma noted that these simple communications correspond to complex behavior. '(This) presented a fundamental mystery to researchers in the field,' she said. She showed how the CETI work magnifies the structure of a coda: 'Even though the clicks might not have sounded like music initially, when we plot them like this, they start to look like music,' she said, presenting a combinatorial coda system. 'They have different tempos and even different rhythm.' This, she added, reveals a lot about the minds of these creatures. 'The resulting set of individual sounds (in the coda) can represent 10 times more meanings than what was previously believed, showing that sperm whales can be much more expressive than what was previously thought,' she said. 'These systems are rare in nature, but not uniquely human. … these results open up the possibility that sperm whales' communication might provide our first example of this phenomenon in another species. … this will allow us to use more powerful machine learning techniques to analyze the data, and perhaps get us closer to an understanding the meanings of their sounds – and maybe (we can) even communicate back.' The research, she added, continues: 'Hopefully the algorithms and approaches we developed in the course of this project empower us to better understand the other species that we share this planet with,' she said. This type of research has a lot of potential!! Let's see what it turns up as we continue through the age of AI.
